Robay, D., Ackermann, O., Laborde, L., Shi, X., Oreglia, F., Stump, R., Ciaghi, S., Galli, G. G., Holzer, L., Villemin, L., Wagner, J., Wu, J., Lee, L. H., Bossen, C., Mourikis, T. P., Gabriel, M., Ruddy, D., Yu, H., Johannessen, C., Ferretti, S., Costa, C. (2026). Targeting CRTC2 reverses
                    <i>STK11</i>
                    mutant NSCLC tumor resistance to immunotherapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2508762123